摘要
It is important to motivate pharmaceutical companies in technological innovation. We study the incentive effects of three types of government subsidies, including R & D subsidies, tax incentives, and non-R & D subsidies, on pharmaceutical companies' innovation. Results show that: 1) R & D subsidies have a significant positive effect on the innovation performance, while tax incentives have no positive impact on this. 2) Tax incentives positively (negatively) affect the innovation performance of state-owned (private) companies. 3) R & D subsidies ease the financing constraints and encourage companies to increase R & D investment, thereby enhancing the innovation. Our findings have implications on inspiring innovation in the pharmaceutical industry.
学科与关键词
- Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in ChinaXia, Yuntian; Fan, Min; Zuo, Xu; Hao, Wenjing; Jia, Yiwen*Frontiers in Psychology, 2023, 13: 1092162.
- Government innovation subsidy, monetary policy, and corporate R&D investment: evidence from ChinaZhang, Yupeng; Huang, Min; Kim, Yoonbai; Wang, Qian*ASIAN JOURNAL OF TECHNOLOGY INNOVATION, 2023, 31(2): 356-374.被引 4
- Public support and energy innovation: Why do firms react differently?Zhang, Hongyan; Zhang, Lin*Energy Economics, 2023, 119: 106528.被引 6
